Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation

enthalten in: Hepatology | 2012

von Lütgehetmann, M. | Mancke, L. | Volz, T. | +8

Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation

enthalten in: Hepatology | 2012

von Lütgehetmann, M. | Urban, S.

Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation

in: Hepatology | 2012

von Lütgehetmann, M. | Mancke, L. | Volz, T. | +8

Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremiaPotential conflict of interest: Nothing to report.

enthalten in: Hepatology | 2008

von Dandri, M. | Murray, J. | Lutgehetmann, M. | +3

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Potential conflict of interest: Dr. Zollner received travel grants from Gilead. Dr. Petersen received grants from Gilead. Dr. Buggisch is on the Speakers' Bureau for and received grants from Schering-Plough. He also received grants from Gilead.

enthalten in: Hepatology | 2006

von Wursthorn, K. | Lutgehetmann, M. | Dandri, M. | +11